Enhancer-dependent splicing of FGFR1 α-exon is repressed by RNA interference-mediated down-regulation of SRp55

Cancer Research

Volumn 64, Issue 24, 2004, Pages 8901-8905

  Jin, Wei ^a   Cote, Gilbert J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; PROTEIN; PROTEIN SRP55; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EXON; GENE SEQUENCE; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; RNA INTERFERENCE; RNA SPLICING; SILENCER GENE; SPLICEOSOME;

ALTERNATIVE SPLICING; BASE SEQUENCE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHORIOCARCINOMA; DOWN-REGULATION; ENHANCER ELEMENTS (GENETICS); EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PHOSPHOPROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; RNA INTERFERENCE; TRANSFECTION;

EID: 10844260793     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0716     Document Type: Article

References (15)

1. Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev 2003;17:419-37.
2. Groth C, Lardelli M. The structure and function of vertebrate fibroblast growth factor receptor 1. Int J Dev Biol 2002;46:393-400.
3. Kobrin MS, Yamanaka Y, Friess H, Lopez ME, Korc M. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res 1993;53:4741-4.
4. Yamaguchi F, Saya H, Bruner J, Morrison RS. Differential expression of two fibroblast factor-receptor genes is associated with malignant progression in human-astrocytomas. Proc Natl Acad Sci USA 1994;91:484-8.
5. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002;3:285-98.
6. Jin W, Huang ES-C, Bi W, Cote GJ. Exon sequence is required for regulated RNA splicing of the human fibroblast growth factor receptor-1 alpha-exon. J Biol Chem 1998;273:16170-6.
7. Jin W, Huang ES-C, Bi W, Cote GJ. Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 alpha-exon recognition in glioblastoma cells. J Biol Chem 1999;274:28035-41.
8. Jin W, McCutcheon IE, Fuller GN, Huang ES-C, Cote GJ. Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. Cancer Res 2000;60:1221-4.
9. Jin W, Bruno IG, Xie T, Sanger LJ, Cote GJ. Polypyrimidine tract-binding protein down regulates fibroblast growth factor receptor 1 alpha exon inclusion. Cancer Res 2003;63:6154-7.
10. Xu R, Teng J, Cooper TA. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol Cell Biol 1993;13:3660-74.
11. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science (Wash DC) 2002;296:550-3.
12. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 2000;31:3568-71.
13. Lemaire R, Winne A, Sarkissian M, Lafyatis R. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation. Eur J Immunol 1999;29:823-37.
14. Hoffman BE, Lis JT. Pre-mRNA splicing by the essential Drosophila protein B52: tissue and target specificity. Mol Cell Biol 2000;20:181-6.
15. Screaton GR, Caceres JF, Mayeda A, et al. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 1995;14:4336-49.